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Chronic reactive oxygen species (ROS) production
by mitochondria may contribute to the development
of insulin resistance, a primary feature of type 2 dia-
betes. In recent years it has become apparent that
ROS generation in response to physiological stimuli
such as insulinmay also facilitate signaling by revers-
ibly oxidizing and inhibiting protein tyrosine phos-
phatases (PTPs). Here we report that mice lacking
one of the key enzymes involved in the elimination
of physiological ROS, glutathione peroxidase 1
(Gpx1), were protected from high-fat-diet-induced
insulin resistance. The increased insulin sensitivity
in Gpx1/ mice was attributed to insulin-induced
phosphatidylinositol-3-kinase/Akt signaling and glu-
cose uptake in muscle and could be reversed by the
antioxidant N-acetylcysteine. Increased insulin sig-
naling correlated with enhanced oxidation of the
PTP family member PTEN, which terminates signals
generated by phosphatidylinositol-3-kinase. These
studies provide causal evidence for the enhance-
ment of insulin signaling by ROS in vivo.
INTRODUCTION
Oxidative stress, or the chronic generation of ROS, is thought to
contribute to the progression of various human diseases
including type 2 diabetes. Oxidative stress in such diseased
states is primarily a biproduct of normal oxidative phosphoryla-
tion chemistry in mitochondria. Superoxide (O2), a natural
biproduct of the single electron transport chain, is generated at
complex I and at complex III (Kim et al., 2008; Veal et al.,
2007). O2 is converted to the ROS H2O2 by superoxide dismu-
tase and then to oxygen and water by antioxidant enzymes such
catalase, thioredoxin, and glutathione peroxidases (Gpxs). In
type 2 diabetes and conditions of morbid obesity, the increased
supply of energy substrates and the inflammatory environment260 Cell Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Iare thought to result in excessive mitochondrial ROS generation
to activate protein kinase signaling pathways that suppress the
insulin signal downstream of the insulin receptor (IR) at the level
of IR substrate-1 (IRS-1) and phosphatidylinositol-3-kinase
(PI3K) to promote ‘‘insulin resistance’’ (Kim et al., 2008; News-
holme et al., 2007; Veal et al., 2007).
Although the excessive production of ROS is associated with
the pathology of many human diseases, in recent years it has
become apparent that low levels of H2O2 may in fact be required
for normal cellular functioning and intracellular signaling. Such
physiological ROS is generated primarily at the plasma mem-
brane and endomembranes by NADP(H) oxidases (Veal et al.,
2007). A wide variety of stimuli including growth factors and
hormones can promote the transient generation of H2O2, and
this has been shown to be essential for optimal tyrosine phos-
phorylation-dependent signaling in vitro (Rhee, 2006; Tonks,
2006). Principal targets of ROS for promoting tyrosine phosphor-
ylation-dependent signaling are the protein tyrosine phospha-
tases (PTPs) (Rhee, 2006; Tonks, 2006). The PTP superfamily
includes phosphatases such as the prototypic PTP1B, which
dephosphorylates tyrosyl phosphorylated substrates, and
enzymes such as PTEN, which dephosphorylates phosphatidyli-
nositol-3,4,5-triphosphate (PIP3) to terminate PI3K signaling. The
architecture of the active site and the low thiol pKa of the invariant
catalytic Cys renders PTPs highly susceptible to reversible oxida-
tion by H2O2 (Tonks, 2006). The oxidation of the active site Cys
abrogates its nucleophilic properties, thus rendering PTPs
inactive. PTPs such as PTP1B and PTEN that regulate insulin
sensitivity and glucose homeostasis in vivo (Elchebly et al.,
1999; Wijesekara et al., 2005) are transiently oxidized by H2O2
in response to insulin in cell-culture systems in vitro to promote
IR activation and PI3K signaling, respectively (Kwon et al.,
2004; Lee et al., 2002; Mahadev et al., 2004; Meng et al., 2004;
Seo et al., 2005). Whether ROS can contribute to the maintenance
of insulin sensitivity in vivo via the inhibition of PTPs is unknown.
Gpxs have a greater affinity (Km = 1 mM) than catalase (Km =
1 mM) for H2O2 and may be the principal enzymes responsible
for eliminating physiologically produced H2O2 that typically
occurs in the low micro- and submicromolar range. Gpx1 is
a ubiquitous cytosolic and mitochondrial antioxidant enzymenc.
Cell Metabolism
ROS and Insulin Sensitivitythat converts intracellular H2O2 to water using reduced gluta-
thione as an electron donor (de Haan et al., 1998). In this study,
we have taken advantage of mice that lack Gpx1 to examine the
role of ROS in PTP regulation and insulin sensitivity and to estab-
lish the potential for ROS to act in a physiological context to
suppress, rather than promote, insulin resistance.
RESULTS
Enhanced ROS, PTENOxidation, and PI3K/Akt Signaling
in Gpx1/ Cells
We used mouse embryo fibroblasts (MEFs) isolated fromGpx1/
versus Gpx1+/+ mice (Figure 1) and determined whether insulin-
induced ROS levels and consequent signaling were altered. We
found that insulin (10–100 nM)-induced H2O2 was elevated
in Gpx1/ MEFs but suppressed by the H2O2 scavenger and
Gpx1 mimetic ebselen (Figure 1A; data not shown). Although
Gpx1 also has the capacity to detoxify lipid hydroperoxides (Ho
et al., 1997), we saw no overt differences in lipid peroxidation in
Gpx1/ versusGpx1+/+ MEFs (data not shown). Insulin promotes
IR b subunit (IRb) Y1162/Y1163 autophosphorylation and activa-
tion, allowing for the phosphorylation of IRS-1 to recruit and acti-
vate the PI3K/Akt and Ras/mitogen-activated protein kinase
(MAPK) pathways, which mediate the metabolic and mitogenic
actions of insulin, respectively. We found that the increased
H2O2 levels in Gpx1
/ MEFs in response to insulin coincided
with elevated PI3K/Akt signaling as measured by Akt Ser-473
phosphorylation (Figure 1B), and this was suppressed by pre-
treating cells with ebselen (Figure 1C), the NADP(H) oxidase inhib-
itor diphenylene iodonium chloride (DPI) (Figure 1C), or the antiox-
idant N-acetylcysteine (NAC; data not shown). Consistent with
ROS serving in the fundamental control of insulin signaling, ebse-
len also suppressed insulin-induced ROS generation (Figure 1A)
and Akt Ser-473 phosphorylation in wild-type MEFS (data not
shown). We did not see any difference in the activation of the
MAPK ERK1/2 inGpx1/ versusGpx1+/+ MEFs (Figure 1B), indi-
cating that signaling in general was not elevated. In addition, we
did not see any global change in insulin-induced tyrosine phos-
phorylation in Gpx1/ versus Gpx1+/+ MEFs (data not shown)
or differences in phosphorylation of IRb on Y1162/Y1163 (Fig-
ure 1D). Consistent with this, we did not see any significant differ-
ence in insulin-induced IRS-1 Y612 phosphorylation (Figure 1E) or
in the binding of the p85 subunit of PI3K to IRS-1 (data not shown).
Thus, the enhanced insulin-induced PI3K/Akt signaling cannot be
ascribed to the insulin-induced oxidation of phosphotyrosine-
specific PTPs such as PTP1B and TCPTP that dephosphorylate
IRb on Y1162/Y1163 (Galic et al., 2005) to terminate the insulin
signal. Instead, these results point toward the elevated ROS
acting downstream of IRb and IRS-1 to selectively regulate
PI3K/Akt signaling.
Previous studies have established that the PTP family member
PTEN, which dephosphorylates the PI3K lipid product PIP3 to
suppress downstream signaling and Akt activation, can be
oxidized and inhibited by H2O2 in response to insulin and
platelet-derived growth factor to promote PI3K/Akt signaling.
The insulin-induced oxidation of PTEN results in enhanced
PTEN electrophoretic mobility when resolved by SDS-PAGE
(Kwon et al., 2004; Lee et al., 2002; Seo et al., 2005). Accordingly,
we assessed the electrophoretic mobility of endogenous PTENCein Gpx1/ versus Gpx1+/+ MEFs in response to insulin or after
the addition of exogenous H2O2 as a measure of PTEN oxidation.
Exogenous H2O2 resulted in significant PTEN oxidation and
concomitant Akt activation (Figure 1F). In Gpx1+/+ MEFs, insulin
induced the oxidation of PTEN to levels seen after the addition of
20–50 mM exogenous H2O2, an extracellular concentration of
H2O2 thought to result in intracellular levels comparable to those
achieved by physiological stimuli (Schroder and Eaton, 2008).
Importantly, Gpx1 deficiency resulted in elevated and prolonged
PTEN oxidation as monitored by the enhanced electrophoretic
mobility in response to insulin (Figure 1G). Furthermore, the
enhanced PTEN oxidation in Gpx1/ cells could be suppressed
to basal levels by pretreating cells with the NADP(H) oxidase
inhibitor DPI (Figure 1H), thus casually linking enhanced PTEN
elecrophoretic mobility to the insulin-induced generation of
ROS. Finally, we assessed PTEN oxidation directly using a modi-
fied cysteinyl-labeling technique that monitors the reversible
oxidation of the active site Cys in PTPs (Boivin et al., 2008).
Gpx1 deficiency resulted in the enhanced basal and insulin-
induced oxidation of PTPs in general and, consistent with our
electrophoretic mobility experiments, in the enhanced oxidation
of PTEN (Figure 1I). Taken together, these results are consistent
with Gpx1 deficiency resulting in elevated ROS levels to tran-
siently oxidize and inhibit PTEN and thus promote PI3K/Akt
signaling.
Enhanced Insulin Sensitivity in Gpx1/ Mice
Having established that Gpx1 deficiency can enhance insulin-
induced PI3K/Akt signaling in vitro by inhibiting PTEN, we next
examined the impact of Gpx1 deficiency on insulin sensitivity
and glucose homeostasis in vivo (Figure 2). Gpx1/ mice are
healthy and fertile, and in the absence of oxidative challenge,
such as that occurring under conditions of cerebral ischemia/re-
perfusion, do not show any overt histopathologies (Crack et al.,
2001; de Haan et al., 1998; Ho et al., 1997). Male 8- to 10-week-
old Gpx1/ versus Gpx1+/+ mice were fed a standard chow diet
for 12 weeks, and insulin and glucose tolerances as well as
fasted blood glucose and insulin levels were determined.
Although no overt differences were seen in insulin tolerance tests
(ITTs) and glucose tolerance tests (GTTs), chow-fed Gpx1/
mice had modest, albeit significantly reduced fasted blood
glucose levels and a tendency toward reduced insulin levels
(see Figure S1A available online), consistent with insulin sensi-
tivity being enhanced. To examine this further, we asked whether
Gpx1 deficiency might enhance insulin sensitivity and afford
protection from high-fat-diet-induced insulin resistance. Male
and female 8- to 10-week-old Gpx1/ versus Gpx1+/+ mice
were fed a high-fat diet (HFD) for a period of 12 weeks. Fasting
plasma insulin levels increased (Figure 2A), and the clearance
of glucose in response to insulin was diminished in high-fat-fed
Gpx1+/+ mice, consistent with the development of insulin resis-
tance (data not shown). Insulin sensitivity, as measured in ITTs,
was significantly enhanced in Gpx1/ mice independent of
gender after high-fat feeding (Figures 2A and 2B). Glucose toler-
ance was improved in female mice (Figure S2A), and insulin
levels during the GTTs were reduced in male mice (Figure S2B;
data not shown), consistent with improved glucose handling.
The improved insulin and glucose tolerances coincided with
significant reductions in fasted blood glucose and reducedll Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Inc. 261
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ROS and Insulin SensitivityFigure 1. Enhanced Insulin-Induced ROS Generation in Gpx1/ Cells Results in PTEN Oxidation and Elevated PI3K/Akt Signaling
(A) MEFs were serum starved for 4 hr, pretreated with vehicle control or ebselen (10 mM, 40 min) and left unstimulated or stimulated with insulin (10 nM, 5 min). CM-
H2DCF-DA (10 mM, 10 min) was added and DCF fluorescence assessed; arbitrary units (AU) are shown.
(B–E) MEFs were serum starved, stimulated with insulin, and processed for immunoblot analysis with antibodies to the Y1162/Y1163 phosphorylated IR b subunit
(p-IRb), Y612 phosphorylated IRS-1 (p-IRS-1), Ser-473 phosphorylated Akt (p-Akt), or the phosphorylated MAPK ERK1/2 (p-ERK1/2) and then reprobed as indi-
cated. Where indicated, cells were pretreated with ebselen (10 mM, 40 min) or DPI (100 mM, 30 min). In (B) and (D), p-Akt or p-IRb was quantified and normalized
for Akt and IRb, respectively. Results shown are representative of three or more independent experiments.
(F)Gpx1+/+ MEFs were serum starved and then stimulated with H2O2 for 5 min, lysed in the presence of 50 mM N-ethylmaleimide (NEM) to irreversibly alkylate free
Cys and prevent the oxidation of Cys postlysis, and processed for immunoblot analysis. Indicated are the reduced (active) and oxidized (inactive) forms of PTEN.
(G and H) Gpx1/ and Gpx1+/+ MEFs were serum starved, preincubated with vehicle control or DPI, stimulated, lysed in the presence of NEM, and processed for
immunoblot analysis. Results shown are representative of three independents experiments.
(I) Gpx1/ and Gpx1+/+ MEFs were serum starved and then stimulated with insulin. Cells were lysed and oxidized PTPs labeled with the sulfhydryl reactive probe
IAP-biotin and subjected to streptavidin-sepharose pull-downs and processed for immunoblot analysis. Results shown in (A), (B), and (D) are means ± SE.262 Cell Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Inc.
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ROS and Insulin SensitivityFigure 2. Insulin Sensitivity Is Enhanced in Gpx1/ Mice
Eight- to ten-week-old Gpx1/ andGpx1+/+ (A) male and (B) female mice were fed a HFD or standard chow diet for 12 weeks. Mice were fasted either for 6 hr and
blood glucose and plasma insulin levels measured, or 4 hr and ITTs performed (0.65 mU insulin/g body weight). Areas under ITT curves were determined.
(C–G) Eight- to ten-week-old Gpx1/ and Gpx1+/+ male mice were fed a HFD for 12 weeks and hyperinsulinemic-euglycemic clamps performed on weight-
matched mice. (D) Glucose infusion and disappearance rates were determined and (E) whole-body glucose production determined by subtracting the glucose
infusion rate from the glucose appearance rate. (F) Livers were harvested at the end of the clamp and processed for quantitative (DDCt) real-time PCR to measure
the expression of the gluconeogenic genes Pck1 (+/+ n = 6,/ n = 5), G6pc (+/+ n = 8,/ n = 7), and Fbp1 (+/+ n = 9,/ n = 8). (G) The uptake of glucose into
white and red gastrocnemius (Gastroc) and diaphragm skeletal muscles, heart, and white adipose tissue (epididymal; WAT) was assessed by administrating
2-deoxy-[1-14C]glucose at the end of the clamp. Results shown in (A)–(G) are means ± SE.fasted plasma insulin (Figures 2A and 2B). Importantly, fasted
plasma insulin in Gpx1-deficient mice was maintained at levels
seen prior to high-fat feeding (data not shown) or after 12 weeks
of standard chow feeding (Figure 2A). No significant difference
was seen in plasma insulin levels from fed Gpx1/ versus
Gpx1+/+ mice (Figure S2C), and no difference was evident in
the initial increase in plasma insulin after bolus glucose adminis-
tration (Figure S2B), indicating that pancreatic b cell insulin
secretion was not altered as a result of Gpx1 deficiency. Instead,
these results suggest that insulin sensitivity may be enhanced in
Gpx1-deficient mice and that the mice are protected from high-
fat-diet-induced insulin resistance. To explore this further, insulin
sensitivity and glucose turnover were measured in high-fat-fed
weight-matched Gpx1/ versus Gpx1+/+ male mice (Figure 2C)
by performing hyperinsulinaemic euglycaemic clamps (Figures
2D–2G). Insulin sensitivity, as measured by the glucose infusion
rate during hyperinsulinemic-euglycemic clamps, was increased
by approximately 3-fold in Gpx1-deficient mice (Figure 2D;
Figure S3). In addition, insulin-stimulated glucose disappear-Ceance, which primarily reflects skeletal muscle glucose disposal,
was increased in Gpx1/ mice (Figure 2D), whereas hepatic
glucose production was not altered (Figure 2E). Consistent
with this, we found no overt difference between Gpx1/ and
Gpx1+/+ mice in hepatic gluconeogenic gene expression as as-
sessed by quantitative real-time PCR (Figure 2F), whereas the
uptake of 2-deoxy-[1-14C]glucose was elevated by approxi-
mately 3- to 4-fold in Gpx1/ white gastrocnemius and dia-
phragm skeletal muscles (Figure 2G). Taken together, these
results indicate that insulin sensitivity is elevated as a result of
Gpx1 deficiency and that this may be attributed to the enhance-
ment of insulin-induced glucose uptake in muscle.
PI3K/Akt Signaling Is Enhanced in Gpx1/ Muscle
Our studies indicate that the enhanced insulin sensitivity in high-
fat-fed Gpx1-deficient mice may be ascribed primarily to the
increased responsiveness of muscle. To test this further, we
assessed the activation of the IR and downstream signaling
pathways in muscle, liver, and fat. Gpx1/ versus Gpx1+/+ll Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Inc. 263
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ROS and Insulin Sensitivitymice fed a HFD for 12 weeks were starved for 4 hr and adminis-
tered saline or insulin and tissues extracted for immunoblot
analysis. We found that insulin-induced IRb Y1162/Y1163 and
IRS-1 Y612 phosphorylation were not altered in either muscle
(Figure 3A), liver, or fat from Gpx1/ versus Gpx1+/+ mice
(data not shown). In contrast, an insulin-induced increase in
Figure 3. Enhanced Insulin-Induced PI3K/
Akt Signaling in Gpx1/ Muscle
Eight- to ten-week-old Gpx1/ and Gpx1+/+ male
mice were fed a HFD for 12 weeks, fasted for 4 hr,
and injected with saline or insulin (0.5 mU/g, intra-
peritoneal); gastrocnemius muscle was extracted
and homogenized, and insulin signaling in indi-
vidual mice was assessed by immunoblot analysis
and quantified by densitometry. Results shown
are means ± SE.
PI3K/Akt signaling, as monitored by Akt
Ser-473 phosphorylation (Figure 3B;
Figure S4A), was evident in muscle from
Gpx1/ but not Gpx1+/+ mice, consis-
tent with Gpx1 deficiency preventing the
development of insulin resistance associ-
ated with high-fat feeding. No difference
was seen in the activation of the MAPKs
ERK1/2, JNK, and p38 in muscle (Fig-
ure S4B), consistent with the selective
activation of the PI3K/Akt pathway. In
line with the elevated PI3K/Akt signaling
in Gpx1/ muscle, we found that the
phosphorylation (Thr642) of the Akt
substrate of 160 kDa (AS160), a Rab
GTPase that regulates GLUT4 docking
at the plasma membrane for glucose
uptake (Larance et al., 2005; Sano et al.,
2003), was increased (Figure 3C),
whereas glycogen synthase Ser-640/641
phosphorylation was reduced (a conse-
quence of Akt phosphorylating and inhib-
iting glycogen synthase kinase 3) (Fig-
ure 3D). No significant difference in
insulin-induced PI3K/Akt signaling was
evident in liver or fat from Gpx1-deficient
mice (Figure S4A). Consistent with this,
we noted no significant difference in
insulin signaling in hepatocytes isolated
from Gpx1/ versus Gpx1+/+ mice (Fig-
ure S5A) or in Gpx1/ versus Gpx1+/+
MEFs that had been differentiated into
adipocytes in vitro (Figure S5B). In
contrast, H2O2 levels as measured by
DCF fluorescence ± ebselen and PI3K/
Akt signaling in response to insulin (0.1–
10 nM) were enhanced in Gpx1/ versus
Gpx1+/+ myoblasts differentiated into
multinucleated myotubes (Figures 4A
and 4B; data not shown); no overt differ-
ence was evident in the differentiation
status of myotubes (data not shown). Consistent with the
elevated PI3K/Akt signaling in Gpx1/ myotubes, knockdown
of Gpx1 (50%) by RNA interference in C2C12 muscle cells
also resulted in increased insulin-induced Akt Ser-473 phosphor-
ylation, and this was suppressed by ebselen (Figure 4C). In
addition, consistent with our findings in muscle in vivo, insulin264 Cell Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Inc.
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ROS and Insulin SensitivityFigure 4. Enhanced Insulin-Induced ROS, PI3K/Akt Signaling, PTEN Oxidation, and Glucose Uptake in Gpx1-Deficient Muscle Cells
(A) Gpx1/ and Gpx1+/+ myoblasts were differentiated into myotubes, serum starved, pretreated with vehicle control or ebselen (10 mM, 40 min), and then either
left unstimulated or stimulated with 1 nM insulin for 5 min before the addition of CM-H2DCF-DA (10 mM, 10 min) and the quantification of DCF fluorescence.
(B) Serum-starved Gpx1/ and Gpx1+/+ myotubes were stimulated with 1 nM insulin for the indicated times and processed for immunoblot analysis. Results
shown are representative of three independent experiments. p-Akt was quantified by densitometric analysis and normalized for total Akt.
(C) C2C12 cells transduced with control or Gpx1 shRNA lentiviral particles were serum starved for 6 hr, pretreated with vehicle control or ebselen, and stimulated
with 1 nM insulin for 10 min. Medium was then replenished and cells collected at the indicated times for immunoblot analysis.
(D) Gpx1/ and Gpx1+/+ myotubes were serum starved in medium with no glucose for 4 hr, stimulated with insulin for 30 min, medium removed and incubated
with 2-Deoxy-D-[2,6-3H]glucose (1 mCi/mL), and incorporated radioactivity measured after 10 min. Results are means ± SD from sixtuplicate stimulations and are
representative of two independent experiments.
(E) Serum-starved Gpx1/ and Gpx1+/+ myotubes were stimulated with 1 nM insulin for the indicated times, IRS-1 immunoprecipitated, and association of the
p85 subunit of PI3K monitored by immunoblot analysis. Results shown are representative of three independents experiments.
(F) Serum-starved myotubes were stimulated with 50 nM insulin for 10 min, IRS-1 immunoprecipitated and associated PI3K activity monitored and quantified as
described in the Experimental Procedures; results are means ± SD from triplicate immunoprecipitations and are representative of two independent experiments.
(Insert) Shown is representative 32P-phosphatidylinositol 3-phosphate (PI3P) generation by the immunoprecipitated PI3K.
(G) Serum-starved Gpx1/ and Gpx1+/+ myotubes were stimulated with 1 nM insulin for the indicated times, lysed in the presence of NEM, and processed
for immunoblot analysis with antibodies to PTEN. Indicated are the reduced and oxidized (inactive) forms of PTEN. Results shown are representative of three
independents experiments.(1–100 nM) induced 2-deoxy-[1-14C]glucose uptake was signifi-
cantly elevated in Gpx1/ myotubes (Figure 4D; data not
shown). Furthermore, as in MEFs, IRS-1 Y612 phosphorylation
(Figure 4B) and insulin-induced IRS-1 p85 PI3K recruitment
(Figure 4E) and PI3K activation (Figure 4F) were not altered, but
PTEN electrophoretic mobility was enhanced in Gpx1/
myotubes (Figure 4G). Taken together, these results indicate
that the enhanced insulin sensitivity in Gpx1/ mice may be
caused by increased ROS for the inactivation of PTEN and theCeenhancement of insulin-induced PI3K/Akt signaling and glucose
uptake in muscle.
ROS Promote Insulin Sensitivity in Gpx1/ Mice
Next, we asked whether the increased insulin-induced PI3K/
Akt signaling in muscle and the enhanced insulin sensitivity in
Gpx1/ mice could be ascribed to increased ROS. We used
Amplex Red to measure H2O2 levels in liver, muscle, and fat
extracts. We also measured H2O2 levels in blood plasma as anll Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Inc. 265
Cell Metabolism
ROS and Insulin Sensitivityindicator of generalized oxidative stress. We found that H2O2
levels were elevated by approximately 3- to 4-fold in muscle,
but not in liver or plasma (Figure 5A); H2O2 could not be detected
in fat using this approach (data not shown). We found no differ-
ence in SOD1 or catalase expression in muscle, liver, or fat
(Figure S6A) and no overt difference in muscle or liver catalase
activity (Figure S6B). Consistent with the elevated H2O2, we
found that the GSH/GSSG ratio (a reduced GSH/GSSG being
Figure 5. The Enhanced PI3K/Akt Signaling
and Insulin Sensitivity in Gpx1/ Mice Can
Be Attenuated by the Antioxidant N-Acetyl-
Cysteine
Eight- to ten-week-old Gpx1/ and Gpx1+/+ male
mice were fed a HFD for 12 weeks and either left
untreated or administered NAC for 7 days
(10 mg/L in drinking water). (A and C) H2O2 levels
in liver, gastrocnemius muscle, or blood plasma
were determined using Amplex Red and normal-
ized to the sample protein content or volume. (B)
GSH/GSSG ratios were determined in muscle
extracts. (D) Mice were fasted and injected with
insulin, gastrocnemius muscle was extracted and
homogenized, and p-Akt signaling in individual
mice was assessed by immunoblot analysis and
quantified by densitometry. (E) Insulin sensitivity
in untreated Gpx1/ versus Gpx1+/+ mice, or
mice administered NAC, was determined by
performing ITTs (0.65 mU/g). Areas under ITT
curves were determined; for clarity, ITT curves
for NAC-treated Gpx1+/+ mice are not shown.
The corresponding fasted blood glucose levels
and body weights determined before and after
NAC treatment are also shown. Results in (A)–(E)
are means ± SE.
an indicator of elevated ROS) was signif-
icantly reduced in Gpx1/ muscle
extracts (Figure 5B), but lipid hydroper-
oxide levels remained unaltered in
Gpx1/ muscle, liver, and fat (data not
shown). Taken together, these results
indicate that H2O2 levels may be elevated
selectively in muscle as a result of Gpx1
deficiency.
Next we determined whether the
elevated ROS was responsible for the
enhanced PI3K/Akt signaling and insulin
sensitivity. High-fat-fed male versus
female Gpx1/ versus Gpx1+/+ mice
were administered the antioxidant NAC
(a H2O2 scavenger and stimulator of
GSH production) for 7 days and either
PI3K/Akt signaling assessed in muscle
extracts after bolus insulin administration
(Figure 5D) or insulin sensitivity assessed
in ITTs (Figure 5E; Figure S7). NAC low-
ered muscle H2O2 and PI3K/Akt signaling
in / mice to levels seen in Gpx1+/+
mice (Figures 5C and 5D). In addition,
NAC administration increased fasted blood glucose in Gpx1/
mice and rendered Gpx1/ mice more insulin resistant so that
they resembled Gpx1+/+ mice, without having any overt effect
on body weight (Figure 5E; Figure S7); NAC did not alter insulin
sensitivity in Gpx1+/+ mice (Figure 5E). These results provide
causal evidence for the involvement of ROS in the enhancement
of insulin signaling/sensitivity in high-fat-fed Gpx1/ mice
in vivo.266 Cell Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Inc.
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ROS and Insulin SensitivityFigure 6. Obesity Resistance and Increased Energy Expenditure in Gpx1/ Mice
(A–C) Eight- to ten-week-old (A and C) male and (B) female mice were fed a HFD, or where indicated a standard chow diet, for 12 weeks. Mice were weighed
and epididymal, infrarenal, and brown adipose (BAT) tissues extracted and weighed. In (C), epididymal fat tissues were processed for immunohistochemistry
(hematoxylin and eosin staining). The cross-sectional diameters of adipocytes (100 cells per mouse) were determined using Image J software (NIH). Represe-
native micrographs and the quantified results are shown.
(D)Gpx1/ andGpx1+/+ MEFs were differentiated into adipocytes and stained with oil red O to monitor lipid content. Representative micrographs and quantified
results are shown.
(E) Eight- to ten-week-old Gpx1/ and Gpx1+/+ male littermates were fed a HFD for 12 weeks, and energy expenditure during the light and dark cycles,
ambulatory movement (x and z axes), and daily food intake were monitored over 48 hr.
(F) Eight- to ten-week-old Gpx1/ and Gpx1+/+ male littermates were fed a HFD for 12 weeks and gas exchange data used to calculate the respiratory exchange
ratio (RER = VO2/VCO2). Carbohydrate versus fat oxidation rates were calculated and expressed as Joules/min.
(G) Eight- to ten-week-old Gpx1/ and Gpx1+/+ male littermates were fed a HFD for 12 weeks, starved for 4 hr, injected with saline or insulin (2 hr, 0.75 mU/g,
intraperitoneal), and diaphragm or gastrocnemius muscle extracted and processed for real-time PCR (DDCt) to measure pdk4 expression. Results in (A)–(G) are
means ± SE.Increased Energy Expenditure and Obesity Resistance
in Gpx1/ Mice
In addition to increased insulin sensitivity, we found thatGpx1/
mice were protected from high-fat-diet-induced obesity (Fig-
ure 6). Gpx1 deficiency reduced epididymal and/or infrarenal
fat accumulation in male and female high-fat-fed mice, and this
was associated with a decrease in body weight but unaltered
food intake (Figures 6A and 6B). Epididymal adipocytes in
Gpx1/ mice were smaller in diameter (Figure 6C), but their
differentiation status as assessed by the expression of PPARg,
AP2, and C/EBP was similar to that of Gpx1+/+ adipocytes
(Figure S8A). In addition, circulating adipokine levels were not
affected (Figure S8B), the differentiation of MEFs into adipocytes
in vitro remained unaltered (Figure 6D), and insulin-induced
lipogenesis in isolated fat pads ex vivo (Figure S8C) was notCeldefective. Thus, these results are consistent with the decreased
adiposity in Gpx1/ mice being attributable to extrinsic factors.
One possibility is that the decreased adiposity may be due to the
enhanced insulin sensitivity and concomitant decreased plasma
insulin, which otherwise promotes lipogenesis. In line with this,
Gpx1/ mice remained more insulin sensitive than their wild-
type counterparts when the genotypes were weight matched
(Figure 2; Figure S9). Thus, these results are consistent with
the increased insulin sensitivity in Gpx1/ mice being indepen-
dent of body weight and for the increased muscle insulin respon-
siveness being a possible driving factor for the lean phenotype.
Since food intake was identical but adiposity decreased in
Gpx1/ mice, we questioned how Gpx1/ mice dealt with
the apparent negative energy balance. We first determined
whether lipids were accumulated in liver and/or muscle andl Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Inc. 267
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Gpx1-deficient mice. Plasma FFA and triglycerides and liver
and muscle ceramides, diglycerides, and triglycerides were not
elevated in Gpx1/ mice (Figure S10A and S10B; data not
shown). Instead, high-fat-fed Gpx1/ mice displayed increased
energy expenditure (Figure 6E) and whole-body carbohydrate
utilization (Figure 6F). The enhanced energy expenditure could
not be accounted for by changes in ambulatory movement
(Figure 6E) or any difference in brown adipose tissue mass
(Figures 6A and 6B) or the corresponding levels of UCP-1
(Figure S11A) that serves to uncouple the electron transport
chain and dissipate energy as heat. Furthermore, the increase
in energy expenditure was not associated with any change in
muscle development (Figures S11B and S11C), muscle mass
(data not shown), or muscle mitochondrial content and/or effi-
ciency as assessed by measuring the activity of citrate synthase
(citric acid cycle enzyme), UCP-3 levels (mitochondrial inner
membrane protein), or by transmission electron microscopy
(Figures S11D–S11F). No significant difference was observed
in fat oxidation rates or in fatty acid oxidation ex vivo in liver,
muscle, or fat explants from fasted Gpx1/ versus Gpx1+/+
male or female mice (Figure S10C; data not shown).
Insulin-induced PI3K/Akt signaling decreases the expression
of muscle pyruvate dehydrogenase kinase 4 (PDK4) that antag-
onizes pyruvate dehydrogenase, the rate-limiting enzyme in
glucose oxidation (Kim et al., 2006; Lee et al., 2004). Accordingly,
we reasoned that the insulin-induced suppression of PDK4 may
be enhanced and thus contribute to the increased carbohydrate
utilization and energy expenditure in Gpx1/ mice. Consistent
with this, we found that pdk4 mRNA (Figure 6G) and protein
(data not shown) levels were suppressed in diaphragm muscle
from fasted Gpx1/ but not Gpx1+/+ mice after a single bolus
administration of insulin (0.75 mU/g, 2 hr). Although PDK4
expression in Gpx1/ gastrocnemius muscle was not signifi-
cantly altered under these conditions, a trend for reduced pdk4
in response to insulin was evident (Figure 6G). Taken together,
these results indicate that Gpx1 deficiency affords resistance
to diet-induced obesity, and this is linked to increased energy
expenditure, which may result from the enhanced insulin-
induced and PI3K/Akt-mediated suppression of PDK4 in muscle
to promote carbohydrate utilization.
Sustained Exercise-Induced Insulin Sensitivity
in Gpx1/ Mice
Our results indicate that a deficiency in Gpx1 mitigates the devel-
opment of diet-induced insulin resistance by maintaining insulin
sensitivity in muscle. Our studies using weight-matched mice
and the antioxidant NAC indicate that the increased insulin
sensitivity is separable from the concomitant obesity resistance.
Nevertheless, we sought to establish an independent model by
which to examine the impact of Gpx1 deficiency and elevated
ROS on insulin sensitivity. Contracting muscle is a major source
of physiological ROS in vivo. Although generated at mitochon-
dria, exercise-induced ROS is transient and has been linked to
the promotion of glucose uptake (Sandstrom et al., 2006).
Furthermore, exercise can promote insulin sensitivity, and this
may occur downstream of the IR and IRS-1 at the level of the
PI3K/Akt pathway (Wojtaszewski et al., 1999, 2003; Zhou and
Dohm, 1997). Therefore, we asked whether insulin sensitivity268 Cell Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Iwas enhanced in Gpx1/ versus Gpx1+/+ mice after a single
bout of exercise. For these experiments, we used chow-fed
mice where differences in body weight were not evident (Fig-
ure 7). Chow-fed Gpx1/ and Gpx1+/+ mice were starved for
12 hr and exercised (30 min running at 16 m/min at a 5 incline),
and then ITTs were performed immediately after and compared
to those undertaken prior to exercise (Figures 7A and 7B). Exer-
cise increased insulin sensitivity, but there was no difference
noted between the Gpx1/ and Gpx1+/+ mice (Figures 7A and
7B). Since Gpx1 serves to eliminate low levels of ROS, we
reasoned that the impact of heightened ROS levels on insulin
sensitivity in Gpx1/ mice may best be seen after a period of
rest, when ROS may be expected to decline in wild-type mice.
To test this hypothesis, exercised mice were rested for 1 hr
and ITTs performed. We found that insulin sensitivity in Gpx1/
mice was significantly enhanced (Figure 7C), and this coincided
with elevated PI3K/Akt signaling as assessed by Akt Ser-473
phosphorylation (Figure 7D). Next we asked whether the
enhanced insulin sensitivity after rest could be attributed to sus-
tained ROS. Gpx1/ versus Gpx1+/+ mice were administered
the antioxidant NAC for 7 days and then exercised, rested, and
ITTs performed once more. We found that the enhanced insulin
sensitivity inGpx1/ mice was reverted to that of wild-type mice
but that insulin sensitivity in wild-type mice remained unaltered
(Figures 7E and 7F). These results are consistent with Gpx1 defi-
ciency and sustained ROS levels prolonging/enhancing the
beneficial effect of exercise on insulin responses.
DISCUSSION
Our studies demonstrate that increasing ROS, as a result of
Gpx1 deficiency, can enhance insulin signaling in vitro and
in vivo to attenuate the development of insulin resistance. Our
results indicate that the enhanced ROS-dependent insulin
signaling in Gpx1/ MEFs and myotubes may be attributable
to the oxidation and inhibition of the PTP superfamily member
PTEN. Previous studies have shown that the catalytic active
site Cys-124 in PTEN is readily oxidized by H2O2 to form a disul-
phide with Cys-71. Furthermore, PTEN oxidation can occur in
cells in response to growth factors and insulin to promote Akt
signaling (Kwon et al., 2004; Lee et al., 2002; Seo et al., 2005).
Our studies suggest that PTEN is the primary, if not the sole,
ROS target that contributes to the enhanced insulin signaling in
Gpx1/ cells, since (1) PI3K/Akt signaling was increased down-
stream of PI3K, (2) PTEN was oxidized in response to insulin, and
(3) PTEN is the only Cys-based lipid phosphatase that dephos-
phorylates the PIP3 product of PI3K to suppress insulin-stimu-
lated glucose uptake (Lazar and Saltiel, 2006; Wijesekara et al.,
2005). The only other PIP3 phosphatases are the inositol poly-
phosphate 5-phosphatases that include SHIP1 and SHIP-2,
but these do not belong to the PTP superfamily and do not
contain a catalytic cysteine subject to oxidation (Hughes et al.,
2000; Ooms et al., 2009). Although insulin-stimulated PTEN
oxidation was modest, this is in keeping with (1) PTP regulation
by ROS being discreet and compartmentalized (Chen et al.,
2008; Ushio-Fukai, 2006); and (2) PTEN’s role in diverse signaling
pathways instigated by growth factors, hormones, cytokines,
and cell-cell/cell-matrix interactions. Furthermore, even though
several tyrosine-specific PTPs have been implicated in thenc.
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(A–C) Chow-fed 10- to 12-week-old mice were starved overnight (12 hr) and (A) ITTs (0.25 mU/g) performed, or otherwise (B and C) treadmill exercised (30 min
running at 16 m/min at a 5 incline) and ITTs performed (B) immediately after or (C) after 1 hr of rest.
(D) Gastrocnemius muscle from exercised and 1 hr rested mice injected with saline or insulin for 30 min was rapidly excised and processed for immunoblot
analysis; results were quantified by densitometric analysis.
(E) Mice from (C) were subsequently administered NAC for 7 days (10 mg/L in drinking water), exercised, and rested for 1 hr, and ITTs were repeated.
(F) Areas under ITT curves from (C) and (E) were determined. Results in (A)–(F) are means ± SE.negative regulation of the IR and IRS-1 (Cho et al., 2006; Dubois
et al., 2006; Elchebly et al., 1999; Galic et al., 2005), our results
suggest that the oxidation of tyrosine-specific PTPs does not
contribute to the enhanced insulin signaling in Gpx1/ MEFs
or mytotubes, since we saw no overt change in IR b subunit
Y1162/Y1163 and downstream IRS-1 phosphorylation and no
difference in Ras/MAPK signaling, which occurs in parallel to
the PI3K/Akt pathway. As in cells in vitro, we found that the
protection from diet-induced insulin resistance in vivo was asso-
ciated with enhanced insulin sensitivity that was attributable to
elevated ROS/PI3K/Akt signaling and consequent AS160 phos-
phorylation and glucose uptake in muscle, but unaltered IR and
IRS-1 tyrosine phosphorylation and unaltered Ras/MAPK
signaling. Although formally ascribing the enhanced insulin
signaling to PTEN oxidation in vivo remains a challenge, our
studies are in line with this possibility. Interestingly, we saw no
difference in ITTs in chow-fed Gpx1/ mice. This is consistent
with the phenotype of muscle-specific PTEN knockout mice,
where increases in insulin sensitivity are only evident after aging
or high-fat feeding (Wijesekara et al., 2005). The apparent redun-Cedancy of PTEN in insulin responsiveness in the chow-fed state
would negate any impact of insulin-instigated PTEN oxidation
and inhibition associated with Gpx1 deficiency.
Despite Gpx1 also being expressed in other tissues, wide-
spread elevated H2O2 or oxidative stress was not apparent in
Gpx1/ mice, and no difference was noted in PI3K/Akt
signaling and consequent gluconeogenesis and lipogenesis in
liver and fat, respectively, pointing toward a functional redun-
dancy. Although it is possible that compensatory changes
may have occurred in other antioxidant pathways, we saw no
difference in SOD1 or catalase expression in liver or fat. More-
over, others have reported that other antioxidant enzymes are
also not altered in Gpx1-deficient mice (de Haan et al., 2006;
Ho et al., 1997). Interestingly, we found that hepatic catalase
activity in wild-type or knockout mice was several-fold higher
than that seen in muscle extracts. Therefore, one possibility is
that the relative abundance/activities of other antioxidant
enzymes in tissues such as the liver may readily counter any
increase in H2O2 that would otherwise be associated with
Gpx1 deficiency.ll Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Inc. 269
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mice can result in insulin resistance and obesity (McClung
et al., 2004). Although these results would appear to be consis-
tent with our findings, subsequent studies from the same group
have demonstrated that lean or obese Gpx1-overexpressing
mice hyperproduce insulin and that isolated Gpx1-overexpress-
ing islets hypersecrete insulin in response to glucose (Wang
et al., 2008). Since heightened insulin exposure has been linked
with diminished insulin sensitivity (Rui et al., 2001; Weyer et al.,
2000), it is likely that the peripheral insulin resistance and
obesity reported for Gpx1 transgenic mice may be ascribed to
the ROS-induced overproduction of insulin in pancreatic b cells.
In our studies, Gpx1 deficiency did not overtly alter insulin
production. In particular, we found that the initial increase in
plasma insulin after bolus glucose administration was similar
between the genotypes. Although insulin levels were lower in
high-fat-fed mice after fasting, this can only be indicative of
enhanced insulin sensitivity as reflected by the coincident
reduction in blood glucose. We provided several lines of evi-
dence to corroborate the enhanced insulin sensitivity. Although
the hyperinsulinemic-euglycemic clamps were undertaken
under anesthesia, substantiating evidence was attained in
ITTs and GTTs and in the assessment of insulin-induced
signaling in vitro and in vivo. As such, our studies provide
compelling evidence for ROS acting in peripheral insulin respon-
sive tissues to enhance, rather than diminish, insulin sensitivity
in vivo.
In addition to enhanced insulin sensitivity, we found that
Gpx1/ mice were protected from high-fat-diet-induced
obesity. The obesity resistance was associated with increased
whole-body carbohydrate utilization, with no apparent decrease
in fat oxidation. The increase in carbohydrate utilization corre-
lated with the enhanced suppression of PDK4 in muscle.
Previous studies have shown that insulin-induced PI3K/Akt
signaling can suppress the expression of PDK4 to promote pyru-
vate dehydrogenase activity (Kim et al., 2006; Lee et al., 2004).
Since Gpx1/ mice were protected from high-fat-diet-induced
insulin resistance and insulin-induced PI3K/Akt signaling, and
downstream PDK4 suppression were enhanced in muscle, we
suggest that Gpx1/ mice may remain lean, at least in part
due to the increased insulin-induced glucose uptake and carbo-
hydrate oxidation in muscle; this would consequently decrease
carbohydrate flux and lipogenesis in adipose tissue. Our studies
indicate that the decreased adiposity in Gpx1/ mice is not
responsible for the enhanced insulin sensitivity since (1) the
elevated insulin signaling was restricted to muscle, (2) the
enhanced insulin sensitivity was evident in weight-matched
mice, (3) NAC treatment diminished insulin sensitivity in Gpx1/
mice to that of control mice without altering body weight, (4) the
enhanced insulin responsiveness and glucose uptake in muscle
could be recapitulated in myotubes in vitro, and (5) Gpx1 defi-
ciency prolonged the beneficial effects of exercise on insulin
sensitivity in chow-fed mice (where body weights did not differ),
and this could be reversed by the antioxidant NAC. Therefore,
these results support the assertion that Gpx1 deficiency and
elevated ROS levels may promote insulin sensitivity independent
of any change in body weight.
Although oxidative stress is generally linked with the develop-
ment of disease, epidemiological studies in humans suggest270 Cell Metabolism 10, 260–272, October 7, 2009 ª2009 Elsevier Ithat antioxidants may decrease life span (Bjelakovic et al.,
2007), whereas other studies indicate that antioxidants may
negate the longer-term beneficial effects of exercise training in
humans by preventing the expression of ROS defense genes
(Ristow et al., 2009). This is consistent with our findings and
the notion that ROS can serve as second messengers that are
integral to fundamental cellular and biological responses
(Rhee, 2006; Veal et al., 2007). However, this does not negate
the involvement of chronic ROS in the progression of diseases
such as diabetes. There are extensive markers associating
ROS with obesity/diabetes in humans and many in vitro studies
demonstrating that ROS can contribute to insulin resistance by
activating protein kinase cascades that directly impinge on the
propagation of signaling past IRS-1 (Newsholme et al., 2007).
Furthermore, direct evidence for the involvement of hypergly-
cemia or obesity-induced ROS in promoting insulin resistance
has been provided using mouse and rat animal models (Ander-
son et al., 2009; Haber et al., 2003; Houstis et al., 2006). In
particular, the antioxidant MnTBAP improves insulin sensitivity
in ob/ob mice that are excessively obese, hyperglycemic, and
insulin resistant (Houstis et al., 2006), whereas inhibiting muscle
mitochondrial ROS generation in high-fat-fed rodents prevents
hyperglycemia and insulin resistance (Anderson et al., 2009).
So why then does Gpx1 deficiency and consequent elevated
ROS enhance insulin sensitivity? We surmise that it is the
degree of ROS generation and the context that determines
whether ROS enhance or suppress insulin sensitivity. Whereas
transient ROS produced by physiological stimuli such as insulin
may be beneficial, sustained mitochondrial ROS generation
associated with hyperglycemia and/or hyperlipidemia in
obesity/diabetes may promote insulin resistance. Anderson
et al. (2009) have reported that a HFD can increase glucose-
induced mitochondrial ROS production in muscle. The HFD
utilized in our studies promoted insulin resistance, but not
hyperglycemia or severe obesity. Thus, we surmise the patho-
logical levels of mitochondrial ROS associated with high-fat
feeding and increased energy substrate availability might not
be achieved. We propose that our studies might reflect the
contribution of ROS to insulin sensitivity early in the develop-
ment of insulin resistance, prior to the onset of hyperglycemia/
hyperlipidemia and frank diabetes. In summary, our studies
provide casual evidence for the enhancement of insulin
signaling by ROS in vivo and suggest that subtle increases in
physiological ROS production in muscle might be of therapeutic
benefit for the treatment of insulin resistance.
EXPERIMENTAL PROCEDURES
Animal Maintenance and Experimental Protocols
We maintained mice on a 12 hr light-dark cycle in a temperature-controlled
facility with free access to food and water. Gpx1/ (de Haan et al., 1998)
and wild-type mice (C57BL/6) were fed standard chow (19% protein, 4.6%
fat, and 4.8% crude fiber) or high-fat (19.5% protein, 36% fat, and 4.7% crude
fiber; Specialty Feeds) diets as indicated. See the Supplemental Experimental
Procedures for details on ITT, GTT, and exercise experiments. Metabolic
monitoring was performed in a Comprehensive Lab Animal Monitoring System
(Columbus Instruments) as described in the Supplemental Experimental
Procedures. Hyperinsulinaemic-euglycaemic clamps were performed on
anesthetized mice after overnight fasting and glucose uptake determined at
the end of the clamp after bolus 2-[1-14C]-deoxyglucose administration as
described in the Supplemental Experimental Procedures.nc.
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MEFs were isolated and cultured as described previously (Shields et al., 2008).
Hepatocytes were isolated by a two-step collagenase A (0.05% w/v) perfusion
as described in the Supplemental Experimental Procedures and cultured in
M199 medium containing 10% (v/v) heat-inactivated FBS plus antibiotics
(100 U/ml penicillin, 100 mg/ml streptomycin) and 1 nM insulin. Where indi-
cated, cells were starved in medium alone for 6 hr. Myoblasts were isolated
from the muscle of 2- to 4-week-old mice and cultured in Ham’s F10 medium
containing 20% (v/v) heat-inactivated FBS, antibiotics, and 2.5 ng/ml human
basic FGF as described in the Supplemental Experimental Procedures. Cells
were differentiated into multinucleated myotubes in DME medium containing
5% (v/v) horse serum (Sigma-Aldrich) plus antibiotics for 5 days. Where indi-
cated, cells were starved in DME medium for 12 hr. [3H]2-deoxyglucose
uptake in response to insulin (0–100 nM, 30 min) was determined as described
previously (Watt et al., 2006). C2C12 immortalized myoblasts (ATCC) were
cultured in DME medium containing 20% (v/v) FBS. For stable knockdown
of Gpx1, control or Gpx1-specific shRNA lentiviral particles (Sigma-Aldrich)
were used to transduce C2C12 cells according to the manufacturer’s instruc-
tions and cells selected in 2 mg/ml puromycin.
ROS Determinations
Intracellular H2O2 was measured in serum-starved MEFs or myotubes loaded
with 10 mM CM-H2DCF-DA and stimulated with 0.1–10 nM insulin as described
in the Supplemental Experimental Procedures. H2O2 levels in tissue extracts or
plasma were determined using the Amplex Red hydrogen peroxide assay kit
(Invitrogen), whereas GSH/GSSG ratios were determined using a BIOXYTECH
GSH/GSSG-412 assay kit (Oxis International Inc).
Reversible PTP Oxidation
PTP oxidation was monitored using a modified cysteinyl-labeling technique
(Boivin et al., 2008). Oxidized iodoacetylpolyethylene oxide (IAP)-biotin-
labeled PTPs were enriched on streptavidin-sepharose and precipitates re-
solved and immunoblotted with streptavidin-horseradish peroxidase or PTEN-
specific antibodies as described in theSupplemental ExperimentalProcedures.
Biochemical Analyses
Tissues were mechanically homogenized in 10–20 volumes of ice-cold RIPA
lysis buffer (50 mM HEPES [pH 7.4], 1% [v/v] Triton X-100, 1% [v/v] sodium
deoxycholate, 0.1% [v/v] SDS, 150 mM NaCl, 10% [v/v] glycerol, 1.5 mM
MgCl_2, 1 mM EGTA, 50 mM NaF, leupeptin [5 mg/ml], pepstatin A [1 mg/ml],
1 mM benzamadine, 2 mM phenylmethysulfonyl fluoride, 1 mM sodium vana-
date) and clarified by centrifugation (100,000 3 g, 20 min, 4C). Cells were
lysed in RIPA buffer plus/minus 50 mM NEM and clarified by centrifugation
(16,000 3 g, 5 min, 4C). For IRS-1 immunoprecipitations, cells were lysed
in NP-40 lysis buffer (50 mM Tris [pH 7.4], 1% [v/v] NP-40, 200 mM NaCl,
50 mM NaF, leupeptin [5 mg/ml], pepstatin A [1 mg/ml], 1 mM benzamadine,
2 mM phenylmethysulfonyl fluoride, 1 mM sodium vanadate) and processed
as described previously (Tiganis et al., 1998). PI3K assays were performed
as described previously (Kong et al., 2000).
Real-Time PCR
Tissues were dissected and immediately frozen in liquid N2 and RNA extracted
using Trizol reagent (Invitrogen). mRNA was reversed transcribed using High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and processed
for quantitative real-time PCR using the TaqMan Universal PCR Master Mix
and TaqMan Gene Expression Assays (Applied Biosystems); Gapdh was
used for normalization. Relative quantification was achieved using the DDCt
method.
Statistical Analysis
A two-tailed Student’s t test was used to test for differences between geno-
types or treatments; *p < 0.05, **p < 0.01, ***p < 0.001.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, 11 figures,
and Supplemental References and can be found with this article online at http://
www.cell.com/cell-metabolism/supplemental/S1097-2765(02)00640-8.CeACKNOWLEDGMENTS
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